Tracy J. Doyle, MD, MPH, and Ivan O. Rosas, MD, FCCP, discuss the findings of their research, suggesting that subclinical rheumatoid arthritis-associated interstitial lung disease is prevalent and that a subset of patients will experience progression of lung disease over time. D. Kyle Hogarth, MD, FCCP, podcast editor of CHEST interviews them and editorialist Gregory P. Cosgrove, MD, FCCP, to review the data, particularly at-risk patients.